Skip to main content

Table 2 Demographic characteristics and clinical data for each group

From: Efficacy and safety of remimazolam besylate versus propofol during hysteroscopy: single-centre randomized controlled trial

 

Group R (n = 41)

Group P (n = 41)

Age (years)

43.8 ± 8.0

45.2 ± 7.0

Height (cm)

159.6 ± 5.2

160.0 ± 4.9

Weight (kg)

62.8 ± 7.6

61.6 ± 8.2

BMI (kg/m2)

24.7 ± 2.7

24.1 ± 2.8

ASA (I/II) (n)

28/13

34/7

Duration of operation (min)

13.2 ± 4.2

12.6 ± 4.7

Duration of awakening (s)

199.0 ± 79.9

59.7 ± 1.2

PACU length of stay (min)

5.44 ± 1.0

6.3 ± 1.9

Total remimazolam (mg/kg)

0.4 ± 0.1

Total propofol (mg/kg)

2.5 ± 0.6

Total remifentanil (μg)

75.7 ± 15.2

73.2 ± 22.2

  1. Note: Data indicate the mean ± SD or n; ASA American Society of Anesthesiologists; BMI body mass index, PACU post anaesthesia care unit